Binge Eating Disorder Therapeutic Market ANALISI DIMENSIONE E QUOTA - TENDENZE DI CRESCITA E PREVISIONI (2024 - 2031)
Binge Eating Disorder Therapeutic Market è segmentato da Drug Class (Anticonvulsant, Antidepressant, Others), Da Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Da Geografia (America del Nord, America Latina, Asia Pacific, Europa, Medio Oriente e Africa). Il rapporto offre il valore (in miliardi di dollari) per i suddetti.
Competitive overview of Binge Eating Disorder Therapeutic Market
I principali attori che operano nel Binge Eating Disorder Therapeutics Market includono Tryp Therapeutics, AstraZeneca plc, Sun Pharmaceutical Industries Ltd, Chronos Therapeutics, Shire US Inc., Eli Lilly and Company, Sunovion Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Johnson & Johnson e Lupin Limited.
Binge Eating Disorder Therapeutic Market Leaders
- Terapeutica di Tryp
- AstraZeneca pl
- Sun Pharmaceutical Industries Ltd
- Cronoterapia
- Shire US Inc.
*Disclaimer: Major players are listed in no particular order.
Binge Eating Disorder Therapeutic Market - Competitive Rivalry, 2023
Binge Eating Disorder Therapeutic Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights